Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Comparing Salvage Radiotherapy in Combination With 6 Months of Androgen-deprivation Therapy Versus Anti-androgen Therapy With Apalutamide in Patients With Biochemical Progression After Radical Prostatectomy

NCT03899077 is registered in ClinicalTrials.gov with Cancer Research Antwerp as lead sponsor.

NCT NCT03899077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Comparing Salvage Radiotherapy in Combination With 6 Months of Androgen-deprivation Therapy Versus Anti-androgen Therapy With Apalutamide in Patients With Biochemical Progression After Radical Prostatectomy
Lead sponsor
Cancer Research Antwerp
Phase
Phase 2
Overall status
Unknown status
Start date
April 5, 2019
Completion date
December 31, 2025
Enrollment
202 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of prostate